Shares of US Nuclear Corp (OTCMKTS:UCLE) continues to move higher in the previous trading session and gained 6% in a week.
On Tuesday, UCLE stock went up 2.50% at $0.4050 with more than 33k shares, compared to its average volume of 42K shares. The stock has moved within a range of $0.3950 – 0.4295 after opening the trade at $0.40.
US Nuclear Corp (OTCMKTS:UCLE) partnered with the Ohio Department of Health Radiation Emergency Preparedness Team for conducting multi-agency flight training operations at Calamityville Training Center in Ohio on June 22-23, 2021. This demonstrated USN’s unique ability to integrate radiation payload data by connecting with the RadResponder Network.
Currently, the only drone vendor having done this, the training exercise engaged US Nuclear’sDroneRad system flying a perimeter around crashed vehicles for gauging, mapping, and reporting fallout from radiological hazards.
The training operation participants included US Nuclear Corp, US Air Force, Ohio Department of Transportation, Wright State University, and Ohio Department of Health. RadResponder Network, the national standard for managing radiological data, has been created through collaboration between DOE, FEMA, NNSA, EPA, and DTRA.
The network enables companies to quickly secure records, share as well as an aggregate significant amount of data managing personnel, equipment as well as multijurisdictional event space. This also ensures that radiological hazards measured by US Nuclear’s drone systems are provided in real-time to different relevant agencies (state, federal, local) enabling them to quickly identify as well as react to threats.
US Nuclear has witnessed increased sales of the DroneRad system due to the unique detection as well as mapping of biological, radiological, and chemical hazards besides the ability to connect to RadResponder for radiation safety and defense.
UCLE stock is trading below the 20-Day and 50-Day Moving averages of $0.42 and $0.43 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.59. The stock is down 22% over the past 3-month.